Hims Hers Health is trading 4.25% up at $29.18, apparently lifted by broad risk-on conditions.
- The stock is outperforming its September 18 close of $27.99.
- No clear company-specific catalyst explains the gain; September 21 coverage highlighted newly announced securities-class-action notices.
- Major indexes are higher as falling oil prices, easing Treasury yields, and AI-led technology strength lifted equities.